by University of East Anglia Credit: Pixabay/CC0 Public Domain Researchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer. Cancer that starts in the bones, rather than cancer that has spread to the bones, predominantly affects children. Current treatment is grueling, with...
UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER IMAGE: “OUR GOAL IS TO BETTER PERSONALIZE THERAPY FOR PROSTATE CANCER PATIENTS, BY PROVIDING THE MOST PRECISE AND ACCURATE ESTIMATES OF THE BENEFIT OF HORMONE THERAPY.” ~ SENIOR AUTHOR, DANIEL E. SPRATT, MD. CREDIT: UNIVERSITY HOSPITALS CLEVELAND–Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is...
AMERICAN ASSOCIATION FOR CANCER RESEARCH Bottom Line: For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic stem cell transplantation (HCT), the two-year overall survival rate has nearly doubled from the period between 2000 and 2004 to the period between 2015 and 2019. Journal in Which the Study...
